How has been the historical performance of Dipna Pharmachem?

Answer:The historical performance of Dipna Pharmachem shows significant fluctuations in its financial metrics over the years. Breakdown: Dipna Pharmachem's net sales have varied considerably, peaking at 727.56 Cr in Mar'22 before declining to 124.92 Cr in Mar'25. The total operating income followed a similar trend, reaching a high of 727.56 Cr in Mar'22 and dropping to 124.93 Cr in Mar'25. The company's operating profit (PBDIT) also saw a decline from 22.10 Cr in Mar'22 to 3.45 Cr in Mar'25, while the profit before tax remained relatively stable at 1.42 Cr in Mar'25, consistent with the previous year. Profit after tax showed a slight decrease from 1.09 Cr in Mar'24 to 0.97 Cr in Mar'25. On the balance sheet, total liabilities were 132.38 Cr in Mar'25, slightly down from 132.90 Cr in Mar'24, while total assets remained nearly unchanged at 132.38 Cr. The company reported a negative cash flow from operating activities of -9.00 Cr in Mar'25, indicating challenges in generating cash from its core operations. Overall, the financial data reflects a company that has experienced significant volatility in its performance metrics over the past few years.